Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

How to elevate your communications testing with AI powered insights and analytics

October 25, 2022 | AI, Behavioural science, Communications, Facial analysis, artificial intelligence 

Learn about a new behavioural science-led framework incorporating AI technologies that ensures you get a true reflection of how your communications materials are consumed and processed by customers

Pharmaceutical companies strive to develop the most effective communication assets for their brands in order to maximise their impact. The challenge though is in identifying the messages and concepts that will have the greatest impact and influence with customers.

While there is now an appreciation of the subconscious behavioural biases that influence how we respond to marketing, many pharmaceutical companies are still developing and testing the majority of their communication campaigns based on more traditional insight gathering.

At Research Partnership, we have developed a behavioural science-led framework incorporating new AI technologies that ensures you get a true reflection of how your communications materials are consumed and processed by customers. watch this webcast to learn about the various components of this new approach and how each of them offered complementary benefits for a recent client who was looking to evaluate their creative concepts.

What you will learn

  • How innovative new technologies can complement traditional research techniques to provide a truer, multi-dimensional picture of how marketing communications perform with the target audience
  • How a new, behavioural science-led approach to communications research can take into account both instinctive and considered thinking as well as other behavioural biases to provide a more holistic evaluation of marketing materials
  • How to make use of AI, facial analysis and implicit response techniques to gain a 360-degree view of communications performance and how this can overcome the limitations of conducting market research remotely in a post-pandemic era

Watch the webcast

This content was provided by Inizio

Company Details

- PMLiVE

Inizio

Email
Website

 Latest Content from  Inizio 

Intelligent field team engagement: Turning shared knowledge into deeper insights and better decisions.

At Age of AI 2026, Inizio Medical’s Phil Wakefield and Inizio Ignite’s Tim Luxford will explore how cross-functional collaboration and AI can unlock faster, more actionable insights across medical and...

AI in practice: 4 real-world use cases in health and life sciences

Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more specific ways – when it...

How will AI change field training?

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

How DataGateway unified oncology data for real-world insights & market intelligence

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.